NCT02171702View on ClinicalTrials.gov

Dose Escalation Study of Oral Treatment With BIBW 2992 in Patients With Advanced Solid Tumours

PHASE1CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

March 31, 2007

Conditions
Neoplasms
Interventions
DRUG

BIBW 2992

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY